Standard

National survey on the current practice and attitudes toward the management of chronic subdural hematoma. / Dutch Subdural Hematoma Research group collaboration.

In: Brain and behavior, Vol. 12, No. 3, e2463, 01.03.2022, p. e2463.

Research output: Contribution to journalArticleAcademicpeer-review

Harvard

Dutch Subdural Hematoma Research group collaboration 2022, 'National survey on the current practice and attitudes toward the management of chronic subdural hematoma', Brain and behavior, vol. 12, no. 3, e2463, pp. e2463. https://doi.org/10.1002/brb3.2463

APA

Dutch Subdural Hematoma Research group collaboration (2022). National survey on the current practice and attitudes toward the management of chronic subdural hematoma. Brain and behavior, 12(3), e2463. [e2463]. https://doi.org/10.1002/brb3.2463

Vancouver

Dutch Subdural Hematoma Research group collaboration. National survey on the current practice and attitudes toward the management of chronic subdural hematoma. Brain and behavior. 2022 Mar 1;12(3):e2463. e2463. doi: 10.1002/brb3.2463

Author

Dutch Subdural Hematoma Research group collaboration. / National survey on the current practice and attitudes toward the management of chronic subdural hematoma. In: Brain and behavior. 2022 ; Vol. 12, No. 3. pp. e2463.

BibTeX

@article{a2bee694b2e14b4490c3bc2b420b3ce4,
title = "National survey on the current practice and attitudes toward the management of chronic subdural hematoma",
abstract = "BACKGROUND: Chronic subdural hematoma (CSDH) is a frequent pathological entity in daily clinical practice. However, evidence-based CSDH-guidelines are lacking and level I evidence from randomized clinical trials (RCTs) is limited. In order to establish and subsequently implement a guideline, insight into current clinical practice and attitudes toward CSDH-treatment is required. The aim is to explore current practice and attitudes toward CSDH-management in the Netherlands. METHODS: A national online survey was distributed among Dutch neurologists and neurosurgeons, examining variation in current CSDH-management through questions on treatment options, (peri)operative management, willingness to adopt new treatments and by presenting four CSDH-cases. RESULTS: One hundred nineteen full responses were received (8% of neurologists, N = 66 and 35% of neurosurgeons, N = 53). A majority of the respondents had a positive experience with burr-hole craniostomy (93%) and with a conservative policy (56%). Around a third had a positive experience with the use of dexamethasone as primary (30%) and additional (33.6%) treatment. These numbers were also reflected in the treatment preferences in the presented cases. (Peri)operative management corresponded among responding neurosurgeons. Most respondents would be willing to implement dexamethasone (98%) if equally effective as surgery and tranexamic acid (93%) if effective in CSDH-management. CONCLUSION: Variation was found regarding preferential CSDH-treatment. However, this is considered not to be insurmountable when implementing evidence-based treatments. This baseline inventory on current clinical practice and current attitudes toward CSDH-treatment is a stepping-stone in the eventual development and implementation of a national guideline.",
keywords = "chronic subdural hematoma, guideline, surveys and questionnaires, traumatic brain injury, treatment",
author = "Holl, {Dana C.} and Jurre Blaauw and Erwin Ista and Dirven, {Clemens M. F.} and Kho, {Kuan H.} and Korn{\'e} Jellema and {van der Gaag}, {Niels A.} and Miah, {Ishita P.} and {den Hertog}, {Heleen M.} and {van der Naalt}, Joukje and Bram Jacobs and {Dutch Subdural Hematoma Research group collaboration} and Dagmar Verbaan and Suzanne Polinder and Lingsma, {Hester F.} and Ruben Dammers",
note = "Publisher Copyright: {\textcopyright} 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC.",
year = "2022",
month = mar,
day = "1",
doi = "10.1002/brb3.2463",
language = "English",
volume = "12",
pages = "e2463",
journal = "Brain and behavior",
issn = "2162-3279",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

RIS

TY - JOUR

T1 - National survey on the current practice and attitudes toward the management of chronic subdural hematoma

AU - Holl, Dana C.

AU - Blaauw, Jurre

AU - Ista, Erwin

AU - Dirven, Clemens M. F.

AU - Kho, Kuan H.

AU - Jellema, Korné

AU - van der Gaag, Niels A.

AU - Miah, Ishita P.

AU - den Hertog, Heleen M.

AU - van der Naalt, Joukje

AU - Jacobs, Bram

AU - Dutch Subdural Hematoma Research group collaboration

AU - Verbaan, Dagmar

AU - Polinder, Suzanne

AU - Lingsma, Hester F.

AU - Dammers, Ruben

N1 - Publisher Copyright: © 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC.

PY - 2022/3/1

Y1 - 2022/3/1

N2 - BACKGROUND: Chronic subdural hematoma (CSDH) is a frequent pathological entity in daily clinical practice. However, evidence-based CSDH-guidelines are lacking and level I evidence from randomized clinical trials (RCTs) is limited. In order to establish and subsequently implement a guideline, insight into current clinical practice and attitudes toward CSDH-treatment is required. The aim is to explore current practice and attitudes toward CSDH-management in the Netherlands. METHODS: A national online survey was distributed among Dutch neurologists and neurosurgeons, examining variation in current CSDH-management through questions on treatment options, (peri)operative management, willingness to adopt new treatments and by presenting four CSDH-cases. RESULTS: One hundred nineteen full responses were received (8% of neurologists, N = 66 and 35% of neurosurgeons, N = 53). A majority of the respondents had a positive experience with burr-hole craniostomy (93%) and with a conservative policy (56%). Around a third had a positive experience with the use of dexamethasone as primary (30%) and additional (33.6%) treatment. These numbers were also reflected in the treatment preferences in the presented cases. (Peri)operative management corresponded among responding neurosurgeons. Most respondents would be willing to implement dexamethasone (98%) if equally effective as surgery and tranexamic acid (93%) if effective in CSDH-management. CONCLUSION: Variation was found regarding preferential CSDH-treatment. However, this is considered not to be insurmountable when implementing evidence-based treatments. This baseline inventory on current clinical practice and current attitudes toward CSDH-treatment is a stepping-stone in the eventual development and implementation of a national guideline.

AB - BACKGROUND: Chronic subdural hematoma (CSDH) is a frequent pathological entity in daily clinical practice. However, evidence-based CSDH-guidelines are lacking and level I evidence from randomized clinical trials (RCTs) is limited. In order to establish and subsequently implement a guideline, insight into current clinical practice and attitudes toward CSDH-treatment is required. The aim is to explore current practice and attitudes toward CSDH-management in the Netherlands. METHODS: A national online survey was distributed among Dutch neurologists and neurosurgeons, examining variation in current CSDH-management through questions on treatment options, (peri)operative management, willingness to adopt new treatments and by presenting four CSDH-cases. RESULTS: One hundred nineteen full responses were received (8% of neurologists, N = 66 and 35% of neurosurgeons, N = 53). A majority of the respondents had a positive experience with burr-hole craniostomy (93%) and with a conservative policy (56%). Around a third had a positive experience with the use of dexamethasone as primary (30%) and additional (33.6%) treatment. These numbers were also reflected in the treatment preferences in the presented cases. (Peri)operative management corresponded among responding neurosurgeons. Most respondents would be willing to implement dexamethasone (98%) if equally effective as surgery and tranexamic acid (93%) if effective in CSDH-management. CONCLUSION: Variation was found regarding preferential CSDH-treatment. However, this is considered not to be insurmountable when implementing evidence-based treatments. This baseline inventory on current clinical practice and current attitudes toward CSDH-treatment is a stepping-stone in the eventual development and implementation of a national guideline.

KW - chronic subdural hematoma

KW - guideline

KW - surveys and questionnaires

KW - traumatic brain injury

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85127730091&partnerID=8YFLogxK

U2 - 10.1002/brb3.2463

DO - 10.1002/brb3.2463

M3 - Article

C2 - 35113493

VL - 12

SP - e2463

JO - Brain and behavior

JF - Brain and behavior

SN - 2162-3279

IS - 3

M1 - e2463

ER -

ID: 23054645